rs10838708

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_002804.5(PSMC3):​c.1127+302C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.387 in 151,976 control chromosomes in the GnomAD database, including 12,358 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.39 ( 12358 hom., cov: 31)

Consequence

PSMC3
NM_002804.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.506

Publications

43 publications found
Variant links:
Genes affected
PSMC3 (HGNC:9549): (proteasome 26S subunit, ATPase 3) The 26S proteasome is a multicatalytic proteinase complex with a highly ordered structure composed of 2 complexes, a 20S core and a 19S regulator. The 20S core is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. The 19S regulator is composed of a base, which contains 6 ATPase subunits and 2 non-ATPase subunits, and a lid, which contains up to 10 non-ATPase subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes one of the ATPase subunits, a member of the triple-A family of ATPases that have chaperone-like activity. This subunit may compete with PSMC2 for binding to the HIV tat protein to regulate the interaction between the viral protein and the transcription complex. A pseudogene has been identified on chromosome 9. [provided by RefSeq, Jul 2008]
PSMC3 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
  • neurodevelopmental disorder
    Inheritance: AD Classification: MODERATE Submitted by: G2P
  • deafness, cataract, impaired intellectual development, and polyneuropathy
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.465 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002804.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PSMC3
NM_002804.5
MANE Select
c.1127+302C>T
intron
N/ANP_002795.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PSMC3
ENST00000298852.8
TSL:1 MANE Select
c.1127+302C>T
intron
N/AENSP00000298852.3
PSMC3
ENST00000619920.4
TSL:1
c.1127+302C>T
intron
N/AENSP00000481029.1
PSMC3
ENST00000602866.5
TSL:1
c.1079+302C>T
intron
N/AENSP00000473652.1

Frequencies

GnomAD3 genomes
AF:
0.387
AC:
58759
AN:
151860
Hom.:
12347
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.223
Gnomad AMI
AF:
0.700
Gnomad AMR
AF:
0.456
Gnomad ASJ
AF:
0.434
Gnomad EAS
AF:
0.262
Gnomad SAS
AF:
0.341
Gnomad FIN
AF:
0.431
Gnomad MID
AF:
0.475
Gnomad NFE
AF:
0.469
Gnomad OTH
AF:
0.416
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.387
AC:
58798
AN:
151976
Hom.:
12358
Cov.:
31
AF XY:
0.384
AC XY:
28535
AN XY:
74252
show subpopulations
African (AFR)
AF:
0.223
AC:
9246
AN:
41468
American (AMR)
AF:
0.457
AC:
6970
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
0.434
AC:
1503
AN:
3460
East Asian (EAS)
AF:
0.262
AC:
1353
AN:
5164
South Asian (SAS)
AF:
0.340
AC:
1639
AN:
4814
European-Finnish (FIN)
AF:
0.431
AC:
4549
AN:
10544
Middle Eastern (MID)
AF:
0.480
AC:
141
AN:
294
European-Non Finnish (NFE)
AF:
0.469
AC:
31864
AN:
67946
Other (OTH)
AF:
0.423
AC:
895
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
1704
3408
5112
6816
8520
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
548
1096
1644
2192
2740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.438
Hom.:
48291
Bravo
AF:
0.382
Asia WGS
AF:
0.311
AC:
1090
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
3.1
DANN
Benign
0.41
PhyloP100
0.51
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10838708; hg19: chr11-47441513; API